Ann Neurol
- SAKOWSKI SA, Koubek EJ, Chen KS, Goutman SA, et al
Role of the Exposome in Neurodegenerative Disease: Recent Insights and Future
Directions.
Ann Neurol. 2024;95:635-652.
J Neural Transm (Vienna)
- MATSUI H, Takahashi R
Current trends in basic research on Parkinson's disease: from mitochondria,
lysosome to alpha-synuclein.
J Neural Transm (Vienna). 2024 Apr 13. doi: 10.1007/s00702-024-02774.
- SCHROTER N, Sajonz BEA, Jost WH, Rijntjes M, et al
Advanced therapies in Parkinson's disease: an individualized approach to their
indication.
J Neural Transm (Vienna). 2024 Apr 13. doi: 10.1007/s00702-024-02773.
- ABDULBAKI A, Wohrle JC, Blahak C, Weigel R, et al
Somatosensory evoked potentials recorded from DBS electrodes: the origin of
subcortical N18.
J Neural Transm (Vienna). 2024;131:359-367.
- FERRUCCI M, Lenzi P, Lazzeri G, Busceti CL, et al
Combined light and electron microscopy (CLEM) to quantify methamphetamine-induced
alpha-synuclein-related pathology.
J Neural Transm (Vienna). 2024;131:335-358.
J Neurol Neurosurg Psychiatry
- YIN Z, Yuan T, Yang A, Xu Y, et al
Contribution of basal ganglia activity to REM sleep disorder in Parkinson's
disease.
J Neurol Neurosurg Psychiatry. 2024 Apr 19:jnnp-2023-332014.
- MAK JKL, McMurran CE, Hagg S
Clinical biomarker-based biological ageing and future risk of neurological
disorders in the UK Biobank.
J Neurol Neurosurg Psychiatry. 2024;95:481-484.
JAMA
- GIBBONS CH, Levine T, Adler C, Bellaire B, et al
Skin Biopsy Detection of Phosphorylated alpha-Synuclein in Patients With
Synucleinopathies.
JAMA. 2024 Mar 20:e240792. doi: 10.1001/jama.2024.0792.
Lancet Neurol
- TOFT M
New gene involved in the pathogenesis of Parkinson's disease.
Lancet Neurol. 2024 Apr 10:S1474-4422(24)00166.
- GUSTAVSSON EK, Follett J, Trinh J, Barodia SK, et al
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association,
and functional analyses.
Lancet Neurol. 2024 Apr 10:S1474-4422(24)00121.
Mov Disord
- WANG Y, Li H, Song N, Xie J, et al
Yeast Prion Protein Sup35 Initiates alpha-Synuclein Pathology in Parkinson's Disease.
Mov Disord. 2024 Apr 16. doi: 10.1002/mds.29810.
- LASS J, Luth T, Schluter K, Schaake S, et al
Stability of Mosaic Divergent Repeat Interruptions in X-Linked
Dystonia-Parkinsonism.
Mov Disord. 2024 Apr 14. doi: 10.1002/mds.29809.
Nat Med
- PAGANO G, Taylor KI, Anzures Cabrera J, Simuni T, et al
Prasinezumab slows motor progression in rapidly progressing early-stage
Parkinson's disease.
Nat Med. 2024;30:1096-1103.
Nervenarzt
- DODEL R, Berg D, Duning T, Kalbe E, et al
[Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and
diagnostics].
Nervenarzt. 2024;95:353-361.
- DODEL R, Berg D, Duning T, Kalbe E, et al
[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment].
Nervenarzt. 2024;95:362-367.
Neurochem Res
- VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
Correction: Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB
Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
Neurochem Res. 2024 Apr 16. doi: 10.1007/s11064-024-04138.
Neurologia (Engl Ed)
- PEREZ-TORRE P, Lopez-Sendon JL, Mananes Barral V, Parees I, et al
Concomitant treatment with safinamide and antidepressant drugs: Safety data from
real clinical practice.
Neurologia (Engl Ed). 2024;39:340-344.
- LUIZ LMD, Marques IA, Folador JP, Andrade AO, et al
Intra and inter-rater remote assessment of bradykinesia in Parkinson's disease.
Neurologia (Engl Ed). 2024;39:345-352.
Neurology
- DOPPLER CEJ, Seger A, Farrher E, Regio Brambilla C, et al
Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior
Disorder.
Neurology. 2024;102:e209271.
PLoS One
- SONG J, Li J, Pei X, Chen J, et al
Identification of cuproptosis-realated key genes and pathways in Parkinson's
disease via bioinformatics analysis.
PLoS One. 2024;19:e0299898.
- ANJUM R, Raza C, Faheem M, Ullah A, et al
Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions
in mouse model of Parkinson's disease through anti-oxidant capacities.
PLoS One. 2024;19:e0302102.
Proc Natl Acad Sci U S A
- MOHD RAFIQ N, Fujise K, Rosenfeld MS, Xu P, et al
Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in
iPSC-derived dopaminergic neurons.
Proc Natl Acad Sci U S A. 2024;121:e2318943121.
Rev Neurol
- DURAN-NAVARRETE MJ, Soto-Voitmann MJ, Torres-Araneda G, Lagos-Gutierrez LD, et al
[Effects on cognitive processes of dual-task training in people with Parkinson's
disease: a systematic review].
Rev Neurol. 2024;78:219-228.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016